{"title":"关于 TSPAN6 通过 syntenin-1 调节 ADSCs-Exos 分泌并促进伤口愈合的研究。","authors":"Zhihua Qiao, Xiancheng Wang, Hongli Zhao, Yiwen Deng, Weiliang Zeng, Jingjing Wu, Yunzhu Chen","doi":"10.1186/s13287-024-04004-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Exosomes (Exos) from adipose-derived stem cells (ADSCs) have a high inclusion content and low immunogenicity, which helps to control inflammation and accelerate the healing of wounds. Unfortunately, the yield of exosomes is poor, which raises the expense and lengthens the treatment period in addition to impairing exosomes' therapeutic impact. Thus, one of the key problems that needs to be resolved in the current exosome study is increasing the exosome yield.</p><p><strong>Methods: </strong>Tetraspanin-6 (TSPAN6) overexpression and knockdown models of ADSCs were constructed to determine the number of exosomes secreted by each group of cells as well as the number of multivesicular bodies (MVBs) and intraluminal vesicles (ILVs) within the cells. Subsequently, the binding region of the interaction between TSPAN6 and syntenin-1 was identified using the yeast two-hybrid assay, and the interaction itself was identified by immunoprecipitation. Finally, cellular and animal studies were conducted to investigate the role of each class of exosomes.</p><p><strong>Results: </strong>When compared to the control group, the number of intracellular MVBs and ILVs was significantly larger, and the number of ADSCs<sup>TSPAN6+</sup>-Exos was more than three times higher. However, TSPAN6's ability to stimulate exosome secretion was reduced as a result of syntenin-1 knockdown. Additional yeast two-hybrid assay demonstrated that the critical structures for their interaction were the N-terminal, Postsynaptic density protein 95/Discs large protein/Zonula occludens 1 (PDZ1), and PDZ2 domains of syntenin-1, and the C-terminal of TSPAN6. In animal trials, the wound healing rate was best in the ADSCs<sup>TSPAN6+</sup>-Exos group, while cellular experiments demonstrated that ADSCs<sup>TSPAN6+</sup>-Exos better enhanced the proliferation and migration of human skin fibroblasts (HSFs) and human umbilical vein endothelial cells (HUVECs).</p><p><strong>Conclusion: </strong>TSPAN6 stimulates exosome secretion and formation, as well as the creation of MVBs and ILVs in ADSCs. Syntenin-1 is essential for TSPAN6's stimulation of ADSCs-Exos secretion. Furthermore, ADSCs<sup>TSPAN6+</sup>-Exos has a greater ability to support wound healing, angiogenesis, and the proliferation and migration of a variety of cells.</p>","PeriodicalId":21876,"journal":{"name":"Stem Cell Research & Therapy","volume":"15 1","pages":"430"},"PeriodicalIF":7.1000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11566053/pdf/","citationCount":"0","resultStr":"{\"title\":\"Research on the TSPAN6 regulating the secretion of ADSCs-Exos through syntenin-1 and promoting wound healing.\",\"authors\":\"Zhihua Qiao, Xiancheng Wang, Hongli Zhao, Yiwen Deng, Weiliang Zeng, Jingjing Wu, Yunzhu Chen\",\"doi\":\"10.1186/s13287-024-04004-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Exosomes (Exos) from adipose-derived stem cells (ADSCs) have a high inclusion content and low immunogenicity, which helps to control inflammation and accelerate the healing of wounds. Unfortunately, the yield of exosomes is poor, which raises the expense and lengthens the treatment period in addition to impairing exosomes' therapeutic impact. Thus, one of the key problems that needs to be resolved in the current exosome study is increasing the exosome yield.</p><p><strong>Methods: </strong>Tetraspanin-6 (TSPAN6) overexpression and knockdown models of ADSCs were constructed to determine the number of exosomes secreted by each group of cells as well as the number of multivesicular bodies (MVBs) and intraluminal vesicles (ILVs) within the cells. Subsequently, the binding region of the interaction between TSPAN6 and syntenin-1 was identified using the yeast two-hybrid assay, and the interaction itself was identified by immunoprecipitation. Finally, cellular and animal studies were conducted to investigate the role of each class of exosomes.</p><p><strong>Results: </strong>When compared to the control group, the number of intracellular MVBs and ILVs was significantly larger, and the number of ADSCs<sup>TSPAN6+</sup>-Exos was more than three times higher. However, TSPAN6's ability to stimulate exosome secretion was reduced as a result of syntenin-1 knockdown. Additional yeast two-hybrid assay demonstrated that the critical structures for their interaction were the N-terminal, Postsynaptic density protein 95/Discs large protein/Zonula occludens 1 (PDZ1), and PDZ2 domains of syntenin-1, and the C-terminal of TSPAN6. In animal trials, the wound healing rate was best in the ADSCs<sup>TSPAN6+</sup>-Exos group, while cellular experiments demonstrated that ADSCs<sup>TSPAN6+</sup>-Exos better enhanced the proliferation and migration of human skin fibroblasts (HSFs) and human umbilical vein endothelial cells (HUVECs).</p><p><strong>Conclusion: </strong>TSPAN6 stimulates exosome secretion and formation, as well as the creation of MVBs and ILVs in ADSCs. Syntenin-1 is essential for TSPAN6's stimulation of ADSCs-Exos secretion. Furthermore, ADSCs<sup>TSPAN6+</sup>-Exos has a greater ability to support wound healing, angiogenesis, and the proliferation and migration of a variety of cells.</p>\",\"PeriodicalId\":21876,\"journal\":{\"name\":\"Stem Cell Research & Therapy\",\"volume\":\"15 1\",\"pages\":\"430\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2024-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11566053/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stem Cell Research & Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13287-024-04004-8\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CELL & TISSUE ENGINEERING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem Cell Research & Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13287-024-04004-8","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0
摘要
背景:来自脂肪源性干细胞(ADSCs)的外泌体(Exos)具有高包涵物含量和低免疫原性,有助于控制炎症和加速伤口愈合。遗憾的是,外泌体的产量较低,除了影响外泌体的治疗效果外,还增加了费用,延长了治疗周期。因此,目前外泌体研究需要解决的关键问题之一就是提高外泌体的产量:方法:构建了四泛素-6(Tetraspanin-6,TSPAN6)过表达和基因敲除的 ADSCs 模型,以确定每组细胞分泌的外泌体数量以及细胞内多囊体(MVB)和腔内囊泡(ILV)的数量。随后,利用酵母双杂交试验确定了TSPAN6和syntenin-1之间相互作用的结合区域,并通过免疫沉淀确定了相互作用本身。最后,通过细胞和动物实验研究了各类外泌体的作用:结果:与对照组相比,细胞内MVBs和ILVs的数量明显增加,ADSCsTSPAN6+-Exos的数量是对照组的三倍多。然而,TSPAN6刺激外泌体分泌的能力因syntenin-1基因敲除而降低。另外的酵母双杂交试验表明,它们相互作用的关键结构是突触后密度蛋白 95/Discs large protein/Zonula occludens 1(PDZ1)的 N 端和 PDZ2 结构域,以及 TSPAN6 的 C 端。在动物实验中,ADSCsTSPAN6+-Exos组的伤口愈合率最好,而细胞实验表明,ADSCsTSPAN6+-Exos能更好地促进人皮肤成纤维细胞(HSFs)和人脐静脉内皮细胞(HUVECs)的增殖和迁移:结论:TSPAN6 能刺激 ADSCs 中外泌体的分泌和形成,以及 MVBs 和 ILVs 的生成。Syntenin-1对TSPAN6刺激ADSCs外泌体分泌至关重要。此外,ADSCsTSPAN6+-Exos 支持伤口愈合、血管生成以及多种细胞增殖和迁移的能力更强。
Research on the TSPAN6 regulating the secretion of ADSCs-Exos through syntenin-1 and promoting wound healing.
Background: Exosomes (Exos) from adipose-derived stem cells (ADSCs) have a high inclusion content and low immunogenicity, which helps to control inflammation and accelerate the healing of wounds. Unfortunately, the yield of exosomes is poor, which raises the expense and lengthens the treatment period in addition to impairing exosomes' therapeutic impact. Thus, one of the key problems that needs to be resolved in the current exosome study is increasing the exosome yield.
Methods: Tetraspanin-6 (TSPAN6) overexpression and knockdown models of ADSCs were constructed to determine the number of exosomes secreted by each group of cells as well as the number of multivesicular bodies (MVBs) and intraluminal vesicles (ILVs) within the cells. Subsequently, the binding region of the interaction between TSPAN6 and syntenin-1 was identified using the yeast two-hybrid assay, and the interaction itself was identified by immunoprecipitation. Finally, cellular and animal studies were conducted to investigate the role of each class of exosomes.
Results: When compared to the control group, the number of intracellular MVBs and ILVs was significantly larger, and the number of ADSCsTSPAN6+-Exos was more than three times higher. However, TSPAN6's ability to stimulate exosome secretion was reduced as a result of syntenin-1 knockdown. Additional yeast two-hybrid assay demonstrated that the critical structures for their interaction were the N-terminal, Postsynaptic density protein 95/Discs large protein/Zonula occludens 1 (PDZ1), and PDZ2 domains of syntenin-1, and the C-terminal of TSPAN6. In animal trials, the wound healing rate was best in the ADSCsTSPAN6+-Exos group, while cellular experiments demonstrated that ADSCsTSPAN6+-Exos better enhanced the proliferation and migration of human skin fibroblasts (HSFs) and human umbilical vein endothelial cells (HUVECs).
Conclusion: TSPAN6 stimulates exosome secretion and formation, as well as the creation of MVBs and ILVs in ADSCs. Syntenin-1 is essential for TSPAN6's stimulation of ADSCs-Exos secretion. Furthermore, ADSCsTSPAN6+-Exos has a greater ability to support wound healing, angiogenesis, and the proliferation and migration of a variety of cells.
期刊介绍:
Stem Cell Research & Therapy serves as a leading platform for translational research in stem cell therapies. This international, peer-reviewed journal publishes high-quality open-access research articles, with a focus on basic, translational, and clinical research in stem cell therapeutics and regenerative therapies. Coverage includes animal models and clinical trials. Additionally, the journal offers reviews, viewpoints, commentaries, and reports.